Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory syncytial virus
Pharma
Sanofi aims to grow Beyfortus after blockbuster sales year
After a strong showing during Beyfortus' first full year on the market, Sanofi is eying further growth opportunities for the RSV antibody.
Fraiser Kansteiner
Jan 30, 2025 11:45am
FDA requires Pfizer, GSK to add new warning label on RSV shots
Jan 8, 2025 11:57am
More testing needed after Moderna trial halted by FDA: experts
Dec 13, 2024 8:15am
American Lung Association launches new GSK-backed RSV campaign
Sep 26, 2024 9:30am
With new CDC guidelines, RSV market value falls sharply: report
Jul 29, 2024 12:04pm
CDC vaccine committee narrows RSV vaccine recommendations
Jun 26, 2024 5:52pm